share_log

RBC Capital Reiterates Outperform on Avid Bioservices, Maintains $8 Price Target

Benzinga ·  Jul 3 21:46

RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment